跳至主要内容
临床试验/NCT02683330
NCT02683330已完成不适用

Mindfulness-based Intervention for People Affected by Parkinson's Disease: A Distant-delivered Randomised Pilot Trial

City, University of London2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Change from baseline Hospital Anxiety and Depression Scale (HADS) at 4, 8 and 20 weeks

研究概览

简要总结

Psychological difficulties, especially depression and anxiety are the most prevalent non-motor symptoms in Parkinson's Disease (PD). Pharmacological treatments are not as effective in PD. Mindfulness courses have received increased popularity and recognition as an effective way to manage emotional states, and there is ever growing findings of the effectiveness of mindfulness courses for people with long-term medical conditions. Two small pilot studies have indicated that mindfulness courses can be helpful for people with PD in improving symptoms of depression, language functioning and motor symptoms. The investigators propose to deliver these courses remotely, through Skype video conferences, to make it more accessible for people with mobility limitations and people who live in rural areas.

详细描述

This study will employ a mixed-methods design, with an experimental randomised control trial followed by a qualitative design. Sixty participants will be randomly assigned to the 8-week mindfulness course (n=30) or a wait-list control group (n=30). Block randomisation will be used and the randomisation scheme will be generated using the randomisation.com website. One-hour sessions will be delivered to groups of 5 people using Skype video-conferencing. As this is a pilot study analyses will largely be descriptive. Further, inferential analyses using mixed modelling will be conducted by intention-to-treat. At the end of the intervention, the investigators will interview the participants of the mindfulness group about their experiences of the course.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • be diagnosed with PD according to PD Brain Bank criteria by a neurologist or geriatrician
  • have a computer and internet access at home, since the course will be delivered via Skype
  • be able to communicate in English fluently
  • be stabilised on mood altering medication and/or Parkinson's medication for a month

排除标准

  • have severe cognitive impairment that would make participation in the mindfulness sessions and home practice of mindful meditation problematic or distressing. This will be assessed using the Telephone Interview for Cognitive Status-Modified (TICS-M, Brandt et al., 1993).
  • have severe psychiatric conditions (e.g. psychosis, drug/ alcohol addiction) that can potentially risk failure in the treatment or limit participation in the course
  • have severe hearing impairment
  • are currently participating in other psychological therapies
  • have prior formal training in mindfulness methods or current meditation practice

结局指标

主要结局

Change from baseline Hospital Anxiety and Depression Scale (HADS) at 4, 8 and 20 weeks

时间窗: Baseline, Mid-intervention (week 4), Post-intervention (week 8) and Follow-up (week 20).

HADS also assessed at Mid-intervention (week 4), Post-intervention (week 8) and Follow-up (week 20) time points.

次要结局

  • Parkinson's Disease Activities of Daily Living Scale (PADLS)(Baseline, Mid-intervention (week 4), Post-intervention (week 8) and Follow-up (week 20))
  • Fatigue Severity Scale (FSS)(Baseline, Mid-intervention (week 4), Post-intervention (week 8) and Follow-up (week 20))
  • Insomnia Severity Index (ISI)(Baseline, Mid-intervention (week 4), Post-intervention (week 8) and Follow-up (week 20))
  • Brief Pain Inventory (BPI)(Baseline, Mid-intervention (week 4), Post-intervention (week 8) and Follow-up (week 20))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Angeliki Bogosian

Lecturer in Psychology

City, University of London

研究点 (2)

Loading locations...

相似试验

Distant Delivery of a Mindfulness-based Intervention... | 临床试验